AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 26609786
Drug: Enoxaparin administered
RxNorm normalized name: enoxaparin
DrugBank: Enoxaparin (DB01225)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin administered through venous line
Trial: 26609786
Drug: Enoxaparin administered
RxNorm normalized name: enoxaparin
DrugBank: Enoxaparin (DB01225)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin administered through arterial line
Trial: 26609786
Drug: Venous line
RxNorm normalized name: bushmaster venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venous line administration of enoxaparin
Trial: 24921919
Drug: Neoadjuvant treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant treatment and surgery
Trial: 19918972
Drug: Acetaminophen (4-g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acetaminophen (4-g bolus dose)
Trial: 17852632
Drug: Step-down regimen
RxNorm normalized name: Kool-Down
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Step-down regimen (5.0 mg/kg per day starting dose and decreasing regimen)
Trial: 17852632
Drug: Standard regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard regimen (2.5 mg/kg per day starting dose and increasing regimen)
Trial: 10633202
Drug: Weekly ferrous
RxNorm normalized name: Ferrous Fumarate
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly ferrous sulfate (60 mg elemental iron)
Trial: 10633202
Drug: Daily ferrous
RxNorm normalized name: Ferrous Fumarate
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Daily ferrous sulfate (60 mg elemental iron)
Trial: 30476654
Drug: Colistin/rifampicin combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colistin/rifampicin combination therapy
Trial: 30476654
Drug: Colistin/rifampicin combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colistin/rifampicin combination therapy with 'partial synergy'
Trial: 30476654
Drug: Colistin/rifampicin combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Colistin/rifampicin combination therapy with 'indifferent' results
Trial: 28412111
Drug: Apneic oxygen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apneic oxygen insufflation (AOI) at 3 L/min for 30 minutes during one-lung ventilation (OLV)
Trial: 25520389
Drug: Aspirin and/or
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin and/or NSAIDs
Trial: 23840145
Drug: Antioxidant therapy
RxNorm normalized name: antioxidant 119
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antioxidant therapy (antox version 1.2-based)
Trial: 17055622
Drug: Reformulated oral
RxNorm normalized name: Tarsum Reformulated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reformulated oral cholera vaccine
Trial: 7677828
Drug: Active allergen
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active allergen avoidance treatment (n = 17)
Trial: 2904753
Drug: Doxazosin (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxazosin (2 to 8 mg)
Trial: 30918221
Drug: Serum TG
RxNorm normalized name: TG-1042
DrugBank: TG-1042 (DB18435)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum TG level <100 mg/dL
Trial: 30918221
Drug: Serum TG
RxNorm normalized name: TG-1042
DrugBank: TG-1042 (DB18435)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serum TG level ≥100 mg/dL
Trial: 27778264
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment plus Chinese herbal medicines (CHMs) for benefiting qi and activating blood circulation
Trial: 18434639
Drug: 2.5 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 g/day mycophenolate mofetil (MMF) plus 20 mg/day prednisone
Trial: 18434639
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus 20 mg/day prednisone
Trial: 17057572
Drug: Laparoscopic cholecystectomy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laparoscopic cholecystectomy (group L)
Trial: 13677549
Drug: Loestrin Fe
RxNorm normalized name: Lo Loestrin Fe
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Loestrin Fe 1/20 (norethindrone acetate 1 mg/EE 20 microg)
Trial: 8874906
Drug: Oral clonidine
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral clonidine (5 micrograms . kg‐1) administered 1.5 hr before surgery, and at 12 hr and 24 hr after initial dose
Trial: 1411952
Drug: 24-hour treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24-hour treatment (cefoxitin or cefotetan)
Trial: 1411952
Drug: 5-day treatment
RxNorm normalized name: 30 day Acne Treatment Kit KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-day treatment
Trial: 1411952
Drug: 24-hour treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24-hour treatment (cefoxitin or cefotetan) in high-risk group (colon wounds)
Trial: 1411952
Drug: 5-day treatment
RxNorm normalized name: 30 day Acne Treatment Kit KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-day treatment in high-risk group (colon wounds)
Trial: 1411952
Drug: 24-hour treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 24-hour treatment (cefoxitin or cefotetan) in high-risk group (ATI > 25)
Trial: 1411952
Drug: 5-day treatment
RxNorm normalized name: 30 day Acne Treatment Kit KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5-day treatment in high-risk group (ATI > 25)
Trial: 2932705
Drug: Diazepam 5
RxNorm normalized name: diazepam 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 5 mg (group B)
Trial: 2932705
Drug: Diazepam 10
RxNorm normalized name: diazepam 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diazepam 10 mg (group C)
Trial: 28716141
Drug: Multicomponent activation
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multicomponent activation therapy for people with MCI or mild to moderate dementia and a brief telephone intervention for informal caregivers.
Trial: 28716141
Drug: Multicomponent activation
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multicomponent activation therapy and caregiver counselling.
Trial: 23945510
Drug: Intravenous dexmedetomidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous dexmedetomidine 1 μg/kg
Trial: 22042184
Drug: Conventional physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional physical therapy (CT)
Trial: 19364334
Drug: Venom Immunotherapy
RxNorm normalized name: bushmaster venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venom Immunotherapy (VIT)
Trial: 9048792
Drug: Epinephrine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epinephrine (1 mg intravenously)
Trial: 8328080
Drug: Budesonide (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide (800 micrograms twice daily)
Trial: 8328080
Drug: Beclomethasone dipropionate
RxNorm normalized name: Beclomethasone Dipropionate
DrugBank: Beclomethasone dipropionate (DB00394)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beclomethasone dipropionate (750 micrograms twice daily)
Trial: 3551508
Drug: Antacid treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antacid treatment (10 ml of an antacid suspension, buffering capacity 85 mmol/10 ml, administered 1 and 3 hours after each meal and at bedtime)
Trial: 27178435
Drug: Bitopertin 3
RxNorm normalized name: Bitopertin
DrugBank: Bitopertin (DB12426)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bitopertin 3 mg
Trial: 27178435
Drug: Bitopertin 10
RxNorm normalized name: Bitopertin
DrugBank: Bitopertin (DB12426)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bitopertin 10 mg
Trial: 27178435
Drug: Bitopertin 60
RxNorm normalized name: Bitopertin
DrugBank: Bitopertin (DB12426)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bitopertin 60 mg
Trial: 27178435
Drug: RG7118 15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RG7118 15 mg
Trial: 27178435
Drug: RG7118 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RG7118 30 mg
Trial: 9143608
Drug: D0870 (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D0870 (50 mg initial dose followed by 10 mg for 4 days)
Trial: 9143608
Drug: D0870 (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D0870 (100 mg initial dose followed by 25 mg for 4 days)
Trial: 9143608
Drug: D0870 (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D0870 (100 mg initial dose followed by 10 mg for 5 days)
Trial: 8196572
Drug: Mexiletine (450
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mexiletine (450 mg per day)
Trial: 3310504
Drug: 5% dextrose
RxNorm normalized name: LMD with 5% Dextrose
DrugBank: D-glucose (DB01914)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% dextrose solution (dextrose group)
Trial: 3310504
Drug: Hartmann's solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hartmann's solution (Hartmann group)
Trial: 3310504
Drug: No intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No intravenous infusion (control group)
Trial: 16389065
Drug: Individualized (broad)
RxNorm normalized name: chloroxylenol
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Individualized (broad) cognitive behavioral therapy
Trial: 16389065
Drug: Manual‐based (focused)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual‐based (focused) cognitive behavioral therapy
Trial: 11251036
Drug: Hydrocortisone infusion
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Hydrocortisone infusion (100 mg followed by continuous infusion of 0.18 mg/kg per h)
Trial: 9235736
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone (GH) 2.0 IU/m2, Norditropin
Trial: 22230409
Drug: Lactobacillus salivarius
RxNorm normalized name: Lactobacillus Salivarius
DrugBank: Lactobacillus salivarius (DB16544)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactobacillus salivarius LS01 (probiotic treatment)
Trial: 9405729
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 group (vitamin D3 300 IU/day + calcium lactate 500 mg/day)
Trial: 9405729
Drug: HRT +
RxNorm normalized name: Hormone Replacement Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HRT + Vit D3 group (2 mg estradiol valerate + 1 mg cyproterone acetate + vitamin D3 300 IU/day + calcium lactate 500 mg/day)
Trial: 9405729
Drug: HRT group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HRT group (2 mg estradiol valerate + 1 mg cyproterone acetate)
Trial: 9405729
Drug: Placebo group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo group (calcium lactate 500 mg/day)
Trial: 9405729
Drug: Non-hormone groups
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Non-hormone groups (Vit D3 and placebo)
Trial: 9405729
Drug: Hormone groups
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hormone groups (HRT and HRT + Vit D3)
Trial: 26654905
Drug: Iodine supplementation
RxNorm normalized name: Iodine
DrugBank: Iodine (DB05382)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iodine supplementation (150 μg/d)
Trial: 24054920
Drug: No occlusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No occlusion and oral anticoagulation
Trial: 14522569
Drug: Clopidogrel (loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (loading dose 300 mg, followed by 75 mg daily) with pre-treatment of atorvastatin or simvastatin
Trial: 14522569
Drug: Clopidogrel (loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clopidogrel (loading dose 300 mg, followed by 75 mg daily)
Trial: 10998024
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate nasal drops 400 microgram once daily
Trial: 8641498
Drug: Determination of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Determination of local antisperm antibodies (Ab) with the mixed antiglobulin reaction (MAR) immunoglobulin (Ig) G and IgA
Trial: 6085376
Drug: Nitrendipine (NTP)
RxNorm normalized name: nitrendipine
DrugBank: Nitrendipine (DB01054)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrendipine (NTP) 5 mg b.i.d. (increased to 20 mg b.i.d. as needed) + Hydrochlorothiazide (HCTZ) 25 mg daily
Trial: 6085376
Drug: Placebo (PLA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (PLA) b.i.d. + Hydrochlorothiazide (HCTZ) 25 mg daily
Trial: 29579168
Drug: Apixaban (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Apixaban (5 mg b.i.d.)
Trial: 29579168
Drug: Vitamin K
RxNorm normalized name: Vitamin K
DrugBank: Phylloquinone (DB01022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin K antagonists (VKA, INR 2-3)
Trial: 9203648
Drug: Hyperimmune anti-HIV
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperimmune anti-HIV intravenous immunoglobulin (HIVIG) 200 mg/kg
Trial: 9203648
Drug: Hyperimmune anti-HIV
RxNorm normalized name: Anti Bac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperimmune anti-HIV intravenous immunoglobulin (HIVIG)
Trial: 3680599
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg sustained release (SR) preparation
Trial: 3680599
Drug: 25 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 25 mg tid dosing regimen
Trial: 3680599
Drug: SR PPA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SR PPA 75 mg
Trial: 27542302
Drug: Adalimumab (loading
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adalimumab (loading dose 80 mg; biweekly dose 40 mg)
Trial: 26386802
Drug: 0.5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg/kg intravenous enoxaparin
Trial: 23885702
Drug: 1.5 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 g/day high‐oleic sunflower ethyl ester oil softgel capsules + foods containing 7 g/day stearidonic acid soybean oil
Trial: 23885702
Drug: 1.5 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 g/day EPA oil ethyl ester softgel capsules + foods containing 7 g/day high‐oleic sunflower oil
Trial: 23885702
Drug: 1.5 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 g/day high‐oleic sunflower ethyl ester oil softgel capsules + foods containing 7 g/day high‐oleic sunflower oil
Trial: 20578930
Drug: 0.25 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.25 mg/kg MPH
Trial: 10203935
Drug: Nicotine cigarette
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine cigarette (.7‐mg estimated nicotine delivery)
Trial: 10203935
Drug: Placebo cigarette
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo cigarette (.05‐mg nicotine delivery)
Trial: 29466961
Drug: Whole brain
RxNorm normalized name: pork brain preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole brain radiation therapy (WBRT)
Trial: 29453872
Drug: Standard of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard of care (treatment by primary medicine team)
Trial: 26917504
Drug: RCT-18 (180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RCT-18 (180 mg, once or twice weekly)
Trial: 26917504
Drug: RCT-18 (360
FDA approved: no
EMA approved: no
PMDA approved: no
Description: RCT-18 (360 mg, weekly)
Trial: 16633117
Drug: Antibiotic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic treatment group (ATG) with ofloxacin or levofloxacin (single dose or BID for 5 days)
Trial: 16633117
Drug: Supportive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Supportive treatment only group (STG)
Trial: 16633117
Drug: Antibiotic treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic treatment group (ATG)
Trial: 12660335
Drug: Diltiazem 120
RxNorm normalized name: diltiazem 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem 120 mg/d
Trial: 12660335
Drug: Diltiazem 180
RxNorm normalized name: diltiazem 180 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem 180 mg/d
Trial: 12660335
Drug: Diltiazem 240
RxNorm normalized name: diltiazem 240 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diltiazem 240 mg/d
Trial: 7071529
Drug: Pneumococcal vaccine
RxNorm normalized name: PNEUMOCOCCAL VACCINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pneumococcal vaccine (subcutaneous injection)
Trial: 7071529
Drug: Influenza vaccine
RxNorm normalized name: Influenza vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Influenza vaccine (subcutaneous injection)
Trial: 7071529
Drug: Pneumococcal vaccine
RxNorm normalized name: PNEUMOCOCCAL VACCINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pneumococcal vaccine (intramuscular injection)
Trial: 3908116
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg AG/day
Trial: 3908116
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g AG/day
Trial: 29596644
Drug: Compound-level intervention
RxNorm normalized name: BENZOIN COMPOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Compound-level intervention (chlorinated drinking water, upgraded sanitation, and handwashing promotion)
Trial: 24963025
Drug: Low-dose S-IFE
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose S-IFE (1 g/kg/d)
Trial: 24963025
Drug: Control dose
RxNorm normalized name: Afeditab CR
DrugBank: Nifedipine (DB01115)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control dose S-IFE (approximately 3 g/kg/d)
Trial: 24963025
Drug: Low-dose S-IFE
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose S-IFE
Trial: 24963025
Drug: Low-dose S-IFE
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose S-IFE and Control dose S-IFE
Trial: 16052544
Drug: Fast-releasing ER
RxNorm normalized name: phentermine hydrochloride Extended Release Oral Tablet [Pro-Fast]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fast-releasing ER formulation
Trial: 16052544
Drug: Medium-releasing ER
RxNorm normalized name: Medium-Chain Triglycerides
DrugBank: Medium-chain triglycerides (DB13959)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medium-releasing ER formulation
Trial: 16052544
Drug: Slow-releasing ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slow-releasing ER formulation
Trial: 16052544
Drug: Slightly-fast-releasing ER
RxNorm normalized name: phentermine hydrochloride Extended Release Oral Tablet [Pro-Fast]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slightly-fast-releasing ER formulation
Trial: 16052544
Drug: Slightly-slow-releasing ER
RxNorm normalized name: ferrous sulfate Extended Release Oral Tablet [Slow-Fe]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Slightly-slow-releasing ER formulation
Trial: 16052544
Drug: 12-h IV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12-h IV infusion of valproic acid (reference)
Trial: 12459665
Drug: IDD-D Propofol
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IDD-D Propofol (2.5 mg/kg bolus + 0.2 mg/kg/min infusion for 30 min)
Trial: 12459665
Drug: IDD-D Propofol
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IDD-D Propofol (30-min infusion)
Trial: 7589025
Drug: Fatty cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fatty cream 0.1% mometasone furoate (EFC)
Trial: 7589025
Drug: Fatty cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fatty cream 0.1% hydrocortisone‐17‐butyrate (LLFC)
Trial: 7004827
Drug: Fenclofenac (900
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenclofenac (900 mg daily)
Trial: 7004827
Drug: Indometacin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indometacin (100 mg daily)
Trial: 28634002
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment + acupressure (AP group)
Trial: 28634002
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment + mock acupressure (mock AP group)
Trial: 20662907
Drug: Initial periodontal
RxNorm normalized name: brigatinib
DrugBank: Brigatinib (DB12267)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Initial periodontal treatment
Trial: 20662907
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no initial periodontal treatment)
Trial: 16004813
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy combined with surgery (36 patients)
Trial: 16004813
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy combined with surgery
Trial: 10677808
Drug: Hydrocolloid patches
RxNorm normalized name: psyllium hydrocolloid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocolloid patches containing TACA (triamcinolone acetonide)
Trial: 10677808
Drug: Hydrocolloid patches
RxNorm normalized name: psyllium hydrocolloid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydrocolloid patches containing TACA